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Abstract
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are autoimmune conditions caused by
Group A Streptococcus (Group A Strep) infections. ARF/RHD are mostly eradicated from the Global North
yet are endemic in many remote Aboriginal and Torres Strait Islander communities of Australia. The risk
factors for ARF/RHD are similar to the material conditions of poverty, including overcrowded housing and
poor access to health services. Despite extensive interventions, surveillance, and evaluation of these
conditions over many years, an entrenched experience of illness persists due to a complex array of social,
material, political, cultural, and economic factors. Using actor network theory (ANT) as a primary
analytical lens I will examine processes leading to the current socio-technical network conformation of
ongoing ARF/RHD. I focus on three nodes, each centring on a different element of this network: firstly,
benzylpenicillin G (BPG) antibiotics used for prevention, secondly, echocardiograms (ECGs) used for
diagnosis and screening, and finally, Group A Strep vaccines that are yet to be developed into a useable
product. For each node I analyse the scientific, policy, and sociological literature by mapping and tracing
associated human and non-human elements and considering how their configurations have changed over
time. Further, I explore the contingent ways in which these nodes have become important elements in
temporarily stabilised network conformations. Despite the persistent and embedded presence of ARF/
RHD in remote Indigenous communities for many decades, the dynamic nature of the network reveals
that this is not an inevitable inequality. Rather, there is vast potential for socially just change through local
Indigenous-led approaches to holistic healthcare.
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Abstract
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are autoimmune conditions
caused by Group A Streptococcus (Group A Strep) infections. ARF/RHD are mostly eradicated
from the Global North yet are endemic in many remote Aboriginal and Torres Strait Islander
communities of Australia. The risk factors for ARF/RHD are similar to the material conditions
of poverty, including overcrowded housing and poor access to health services. Despite
extensive interventions, surveillance, and evaluation of these conditions over many years,
an entrenched experience of illness persists due to a complex array of social, material,
political, cultural, and economic factors. Using actor network theory (ANT) as a primary
analytical lens I will examine processes leading to the current socio-technical network
conformation of ongoing ARF/RHD. I focus on three nodes, each centring on a different
element of this network: firstly, benzylpenicillin G (BPG) antibiotics used for prevention,
secondly, echocardiograms (ECGs) used for diagnosis and screening, and finally, Group A
Strep vaccines that are yet to be developed into a useable product. For each node I analyse
the scientific, policy, and sociological literature by mapping and tracing associated human
and non-human elements and considering how their configurations have changed over
time. Further, I explore the contingent ways in which these nodes have become important
elements in temporarily stabilised network conformations. Despite the persistent and
embedded presence of ARF/RHD in remote Indigenous communities for many decades, the
dynamic nature of the network reveals that this is not an inevitable inequality. Rather, there
is vast potential for socially just change through local Indigenous-led approaches to holistic
healthcare.
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Chapter 1: Introduction
Topic Overview
In this thesis I examine the ongoing presence of endemic acute rheumatic fever (ARF), and
its sequela, rheumatic heart disease (RHD) in remote Indigenous communities of Australia.
ARF/RHD are debilitating, yet preventable diseases, that are commonly associated with
material conditions of impoverishment and disadvantage (Watkins et al. 2018, p. 1398).
ARF/RHD primarily impact young people in developing nations, and Indigenous communities
within developed nations. ARF/RHD are conditions caused by Group A Streptococcus (Group
A Strep) bacterium infection (Welch et al. 2020, p. 121). Group A Strep is a member of the
Streptococcus pyogenes bacterial species and is known for its pathogenicity, causing a wide
range of diseases in humans (Reglinski and Sriskandan 2015, p. 675; May, Bowen and
Carapetis 2016). ARF manifests in genetically susceptible individuals as an autoimmune
response to Group A Strep infection (Dooley et al. 2021, p. 3). A common result of ARF is
lasting damage to heart valve tissues, most likely caused via cross-reactivity in which
immune cells inadvertently attack host tissues, as well as Group A Strep (Gray et al. 2017).
Scientific understandings of the biological mechanisms of this autoimmune reaction remain
under investigation (Dooley et al. 2021). After an initial ARF episode, the heart valves
become vulnerable to subsequent Group A Strep infections (Watkins et al. 2018, p. 399).
Following recurrent ARF episodes or a single extreme incident, RHD can develop due to
irreversible damage to the mitral and/or aortic heart valves that can no longer maintain a
unidirectional flow of blood through the heart (Jackson, Steer and Campbell 2011, p. 2).
Without a combination of long-term antibiotic administration, early diagnosis, heart failure
medication, heart surgeries, and lifelong usage of anticoagulants, RHD can lead to issues
such as “heart failure, stroke and infective endocarditis” and ultimately preventable death
in the sufferer (RHDAustralia 2020, p. 286).

Recently, there has been a push for global action towards Group A Strep vaccine
development, led by the World Health Organisation (World Health Organisation 2018;
Vekemans et al. 2019). To date, there has been limited success in this venture due to a
variety of factors including inadequate understanding of the diverse mechanisms of Group A
Strep pathogenesis, and the large diversity of genetic variants and strains in hyperendemic
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areas (Dooley et al. 2021; Kumar and Tandon 2013; McDonald, Currie and Carapetis 2004).
Despite growing global attention, ARF/RHD rates are increasing in Aboriginal and Torres
Strait Islander communities. In this introductory chapter I provide a background of
ARF/RHD, highlight the sociological significance of this health inequality, and convey some
of the persisting issues with prevention programs. I close this chapter with my thesis
outline.

Background
In the 1930s-40s ARF was a prominent illness in Australia. It was considered a common
disease in children with low socio-economic status (150 per 100000) and moderately
common in children from a wealthier background (47 per 100000) (Steer 2015). Due to a
variety of factors, such as a general rise in standards of living and the development of
penicillin antibiotics to treat Group A Strep infections (Jackson, Steer and Campbell 2011),
case numbers have gradually declined (Wyber, Johnson and Patel 2015). Despite broad
improvements across Australian society and in other industrialised nations, ARF/RHD
remains a global health concern (Watkins et al. 2018, p. 1398). While reports vary widely
and are likely an underestimation of prevalence (Paar et al. 2010), RHD affects
approximately 33-40 million individuals around the world and causes over 350000 deaths
per year (Katzenellenbogen et al. 2020; Macleod et al. 2019b).

In Australia, ARF/RHD is present endemically in remote Aboriginal and Torres Strait Islander
communities, while in non-Indigenous populations, it is either unknown or largely
considered eradicated (Parnaby and Carapetis 2010, p. 527). The group most commonly
diagnosed with ARF are young Indigenous females aged 5-14 years old that live in remote
communities (Katzenellenbogen et al. 2020). There are approximately 6000 people
diagnosed with RHD in Australia, 71.2% of whom are Aboriginal and Torres Strait Islander
peoples (Wyber et al. 2020; Katzenellenbogen et al. 2020). Each year 500 new RHD cases
emerge with 90% of these affecting Indigenous peoples, two thirds of whom are female
(Katzenellenbogen et al. 2020). These statistics reflect an ongoing state of endemic illness in
remote Indigenous communities, indicative of systemic health inequality in the Australian
context.
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The Surface of the Issue?
Primary prevention of Group A Strep treats early signs of superficial infections with
antibiotics to avoid disease progression to ARF/RHD. Numerous failed attempts at
systematic primary prevention have resulted from under-resourcing, underfunding, and
insensitivity to the complexities of the task (Wyber et al. 2020). In Australian Indigenous
communities with endemic ARF, Group A Strep is commonly contracted via skin sores
(Parnaby and Carapetis 2010), while in most other contexts it is contracted via an infection
of the nose or throat resulting in pharyngitis (Steer 2015). These infected skin sores are
known as impetigo and are highly contagious (Reglinski and Sriskandan 2015). This unique
mode of infection in remote communities means that efforts for early detection, via skin
swabs, and appropriate antibiotic treatments are ungeneralisable to most other
international endemic settings where pharyngitis is the primary mode of infection (Wyber et
al. 2021; Amgarth-Duff et al. 2019). While the causal link between impetigo and ARF
remains poorly understood and underexamined in clinical settings (Yeoh et al. 2017), the
strong concurrence is undeniable (O’Sullivan et al. 2017) indicating the need for further
investigation of this unique mode of transmission in remote Australia.

A Material Health Injustice
The endemic occurrence of ARF/RHD in remote Indigenous communities of Australia is
strongly associated with environmental factors linked with poverty and socio-economic
disadvantage (Haynes et al. 2020). These factors, such as overcrowded housing, poor access
to healthcare, and limited or unclean water supplies, are ideal conditions for contagious
bacterial transmission (Barnett, Bowen and Carapetis 2018). As these are material concerns
determined largely by poor access to resources, ARF/RHD are often considered
“preventable diseases of socio-economic disadvantage” (Dooley et al. 2021, p. 8). Despite its
preventability, ARF/RHD persists in remote regions of Australia (Carapetis and Brown 2020).
The Northern Territory (NT) has the greatest ARF/RHD cases (3544.08 per 100000), followed
by Western Australia (WA) (1012.3 per 100000) and Queensland (QLD) (862.1 per 100000)
(Katzenellenbogen et al. 2020). The availability of these case numbers reflects improving
detection methods, statistical analysis, disease registration, and surveillance techniques,
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which assist greatly in refining the official understanding of disease epidemiology and
population trends (May, Bowen and Carapetis 2016). At the same time, they highlight the
extreme and disproportionate impact of ARF/RHD in regions with large and diverse
Indigenous populations and where established infrastructure and access to resources is
critically inadequate.

While case numbers continue to grow and data collection techniques are expanded and
refined, there remains an absence of holistic primordial prevention programs – ones that
seek to address the socio-material inequalities leading to ARF/RHD (Parnaby and Carapetis
2010; RHDAustralia 2020, p. 36). The policy and funding focus over recent decades has not
been directed towards sustainable projects for systemic improvements. Rather, they have
consistently focused on collecting data for evaluation of existing prevention programs and
increasing the reach of population health statistics (Health Policy Analysis 2017, p. 3). The
material conditions of poverty enabling the endemic experience of ARF/RHD in remote
Indigenous communities are malleable, and the persistence of these conditions in one of the
most affluent nations in the world is entirely avoidable (May, Bowen and Carapetis 2016, p.
202). Prioritising efforts to inhibit initial Group A Strep infection, such as through provision
of culturally appropriate housing to reduce overcrowding (RHDAustralia 2020, p. 45), could
lead to sustainable healthy environments, preventing key risks associated with this severe
inequality.

Biomedical Models in Indigenous Healthcare
ARF/RHD prevention, treatment, education, and research has been historically produced
through Western biomedical models of health and illness (Haynes et al. 2021, p. 2). Utilising
a biomedical lens positions illness within the biological site of the body and evaluates its
medical treatability (Saggers and Gray 2007, pp. 1-3). The focus on curing bodily disease in
the biomedical model formulates healthcare in terms of case numbers, key performance
indicators (KPIs), and quantitative goals, fundamentally reducing the role of systemic
intergenerational inequality to an isolated numerical measure (Khoury 2015, p. 483). Haynes
et al. (2020, p. 9) identify the tendency of biomedical texts to describe ARF/RHD as a
“disease of poverty” while employing minimal effort towards understanding the
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mechanisms that lead to associated conditions of impoverishment. Additionally, biomedical
models have been criticised as a largely incongruent approach to Indigenous health
concerns (Wyber et al. 2020, p. 46), simultaneously dismissing Indigenous knowledges while
reinforcing colonial norms in institutional settings (Sabati 2019, pp. 1061-1062).

Alternatives to the systemic epistemological dominance (Rix et al. 2019) of biomedicine in
the ARF/RHD project is now a tangible possibility with novel multi-stakeholder proposals
emerging that privilege Indigenous voices and research (Wyber et al. 2020; RHDAustralia
2020). However, it remains crucial to investigate and reconsider the many aspects of this
preventable illness which have led to its entrenched normalisation in Indigenous Australia
(Haynes et al. 2020, pp. 9-10). For example, consideration of the social determinants of
health accounts for many broader issues that contribute to a person’s state of wellness,
such as socioeconomics and education (Heard et al. 2019). The continuing mainstream focus
on data, biomedical care, and reactive treatment regimens have failed to reduce the health
inequality of ARF/RHD. Greater attention to the broader system of processes leading to
socio-material disadvantage could reveal opportunities for holistic prevention and realign
the focus to the reduction of inequality beyond ARF/RHD. This is what I examine here
through the lens of actor network theory (ANT).

Research Questions and Thesis Outline
Through an analysis of ARF/RHD literature, I will consider the following research questions:
(1) What are some of the socio-technical and material aspects of ARF/RHD in Australia that
have led to its endemic and ongoing presence in remote Aboriginal and Torres Strait Islander
communities? (2) How has the construction of ARF/RHD changed over time? (3) Are there
any opportunities for alternative ways of approaching prevention of ARF/RHD?

In the next chapter I describe my analytical and methodological approach. I draw on actor
network theory (ANT) as a primary lens of analysis, with additional insights from ethics of
care, governmentality theory, and post-colonial studies. I consider ARF/RHD as a sociotechnical network comprised of a contingent assembly of disparate human and non-human
actors, tools, and techniques. These actors each play unique roles through their situated
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interactions that stabilise and shift the conformation of the network over time in response
to network processes of power, knowledge, and communication. In the subsequent three
chapters, I present my findings. Each chapter centres on a different focal non-human
network actor called technological nodes. These nodes are important network components
that shape and are shaped by activities, decisions, and expectations of surrounding actors.
ANT is a useful approach to this investigation as it highlights the combined importance of
social, technical, biological, and material dimensions of the ARF/RHD issue. This enables the
examination of the ways the focus of research and the areas of most concern to key actors
have shifted over time. These shifts were contingent and dynamic, signalling opportunities
for more change into the future that is inclusive of alternate voices that sometimes go
against the mainstream flow of knowledge.

I have organised the three findings chapters in order of the historical stability of each
technological node in the network. The benzylpenicillin G (BPG) chapter highlights the
elevated role of antibiotics as a mainstay of ARF/RHD prevention and treatment despite the
ever-increasing burden of illness, showing the ways that the responsibility for care in
addressing ARF/RHD has been placed largely on this biomedical actor and shifted away from
community leadership. The echocardiogram (ECG) chapter explores the ways that
standardisation can both obscure and visiblise marginal groups that do not conform with
normalised disease presentations, and the ways that expertise draws boundaries in
networks that can be overcome through de-professionalisation processes. The vaccine
chapter outlines the ways that material aspects of Group A Strep and long term
expectations of success contribute to an extended narrative that promises development of a
safe and effective vaccine yet has not delivered, leading some advocates to suggest that
primordial prevention is the key to holistic ARF/RHD prevention. I end with a brief
conclusion outlining key findings and make suggestions for future research.
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Chapter 2: Analytical and Methodological Approach
Introduction
Undertaking sociological research on ARF/RHD prevention and treatment in Australian
remote Indigenous communities is crucial to understanding this condition beyond the
mainstream biomedical framing of health, illness, and disease (Haynes et al. 2014). In this
chapter I discuss the main theoretical approaches I will draw on and how they can be
usefully brought together. Firstly, I will identify the key aspects of actor network theory
(ANT) that will help me to show the role of both human and non-human actors and the ways
they are stabilised in various conformations over time. Then I examine the ways that ANT
can be bolstered with insights from ethics of care, governmentality, and post-colonial
studies of technoscience. In the final section I describe my data collection and analysis.

Actor Network Theory Overview
ANT is a Science and Technology Studies (STS) approach to sociological analysis that
highlights the researcher’s role in mapping out associations and interactions between
human and non-human actors in socio-technical networks (Latour 2005; Law 1992).
Networks are webs of relations between diverse actors that are arranged by the “uncertain
consequences of ordering heterogenous materials” (Law 1992, p. 390). This way of thinking
about socio-technical networks radically rejects the exclusive humanness of “society” which
has been “traditionally seen as a separate domain of reality” (Latour 2005, p. 3). Instead, it
attends to the many material elements (including people and technologies) that interact,
repel, and stabilise to make up a dynamic socio-technical arrangement. The elements of a
network could be small and mundane, such as a paper note written by the pen in the hand
of a clinician, or much more advanced, such as complex high-throughput bioinformatics
technologies. In each case, ANT facilitates the consideration of the ordering “energies” that
flow between actors and that are often overlooked in other restrictive techniques of
appraisal that only see what is there and not how it came to be (Latour 2005, p. 17).
Network energies, such as power, knowledge and communication, travel through network
spaces, connecting and stabilising human and non-human elements around existing
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objectives (McCarthy and Martin-McDonald 2007, p. 84) or harnessing their potential to
move their position to achieve new goals (Latour 1990).

Guided by ANT concepts and vocabulary, I will interpret the diverse arrangements of
elements in ARF/RHD as a network of actors that perform unique and consequential roles in
reproducing and resisting the unjust assemblage of endemic ARF/RHD. The human and nonhuman actors in this assemblage are considered symmetrically as participants that each
contribute to the maintenance of the ARF/RHD network composition (Callon and Latour
1981, p. 280). Energies work to stabilise the network in a mutually negotiated or coercive
conformation. The results of these stabilising interactions can be harmonious, leading to a
subdued collaboration between actors that reflects a common purpose. At other times,
these goals are resisted, leading to movement and defiance against powerful energy flows.
It is at these resistant junctures of the network that the possibility of gradual change and
rearrangement exists (McCarthy and Martin-McDonald 2007, p. 95). A network cannot
remain in a state of flux indefinitely, and this leads to compromise, innovation, and
adjustment that is continuous with previous network forms. This does not necessarily
exclude existing actors and their roles, rather it shifts them to a more favourable location in
the network, making way for new processes and positioning, relative to others (McCarthy
and Martin-McDonald 2007, p. 85).

ANT, Care, and Change
ANT is less a theory and more a way of attending to the surprising ways that many actors
interact and are situated in relation to others in a network (Mol 2010, p. 261). While some
may see the formlessness of this framework as a weakness due to its lack of reproducibility
across contexts, it is rather a huge strength when analysing issues such as ARF/RHD that
have been considered through the same biomedical lens for decades. By commencing this
analysis with the intention to understand the ways that the ARF/RHD network has been
constructed over time, I will be free from the explanatory frames that so often confine and
direct research of “the social” (Latour 2004, pp. 16-17). In considering the ways the network
has been assembled, my attention will be drawn to the localised issues of ARF/RHD
prevention and treatment in remote Indigenous Australia. Subsequently, I will be sensitised
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to this network’s propensity for change as a constructed socio-material arrangement. What
has been constructed can thus be critically unconstructed and reconstructed (Latour 2004)
into a more socially just conformation.

This social justice concern aligns with the framing of critique via “matters of care” proposed
by Puig de la Bellacasa (2011). Building on Latour (2004) and feminist ethics of care, Puig de
la Bellacasa puts forward care as an “ethico-political” commitment to the heterogenous
things in an assembled network. By drawing on the traditionally feminist concern of care as
an undervalued domestic labour, this concept can be effectively employed in
technoscientific spaces with the intention of gathering network elements together in a
mutualistic arrangement through the caring work of the sociologist. In doing so, it gives
“significance to particular socio-material practices by generating care for undervalued and
neglected issues” (Puig de la Bellacasa 2011, p. 94). This work towards a caring analysis
involves attending to all connected actors that may share oppositional views, but that must
be considered in a respectful manner, no matter who or what they are. This approach
moderates the fundamentalism that can otherwise emerge through strong critiques and
avoids the broad stroke diagnoses that often feature in reductionist arguments. This
approach does not exclude power relations from the analysis but rather redirects them from
being seen as a political motive by “evil” actors, towards a more dispersed political process
that absolutely produces a network effect, whether intended or otherwise. Further, this
approach reveals that the caring load could be shared across network spaces more evenly to
avoid reliance on discrete actors from hegemonic knowledge systems and by doing so,
“share the burden of stratified worlds” (p. 94).

Latour (2004, p. 232) and Puig de la Bellacasa (2011) argue that the heavily critical focus of
STS requires a reorientation towards an ethos of protection and care, and away from
debunking and deconstruction. Additionally, Law and Singleton (2013, p. 485) suggest that
ANT is not geared towards the formulation of immediate solutions, but is rather a sensitising
craft that appreciates the “slow processes of knowing”. I believe that it is this sensitive,
empirical teasing out and intensive deliberation of how the ARF/RHD network has come to
be in its current state that will unlock a door to new possibilities for remote Indigenous
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peoples. It is this articulation of contextual and political issues and the belief that a better
world could exist that could lead to a socially just ARF/RHD network reassemblage.

A Powerful Addition to ANT
In some of the early canonical works of ANT, scholars examined a variety of topics, such as
scallop domestication (Callon 1986) and pasteurisation (Latour 1988), exemplifying the
radical significance of human/non-human symmetry in socio-material reconstructions and
challenging the idea of predetermined structures in society (Baiocchi, Graizbord and
Rodriguez-Muniz 2013, p. 324). This led to a common critique that ANT is “apolitical”, a
suggestion that has been consistently contested by diverse and adaptive interpretations of
society that attend to the assembling forces of political processes that must be drawn out,
examined and not presumed (Baiocchi, Graizbord and Rodriguez-Muniz 2013, p. 337; Latour
1990). To bolster my inquiry into the ARF/RHD network’s propensity for adaption over time,
governmentality provides an analytical approach that attends to the ways that human
behaviours are directed across diverse contexts, particularly by government (Foucault as
cited in Rose, O’Malley and Valverde 2006). This lens will help me demonstrate the way
interests that work to stabilise networks are not a constant state of reality, but rather a
series of processes that are alterable. I will supplement ANT with governmentality and
extend it to include non-human actors as both influenced and influencer in the political
regions of this complex socio-material network.

Governmentality considers government as a complex of entities, institutions and tools that
interact to enable political power to be exercised upon people (Foucault as cited in Rose,
O’Malley and Valverde 2006, p. 86). This theory reflects an analytical shift in focus from
traditional sovereign nations with central rule, to these “ensembles” of government
associated with governable populations. Populations are understood in terms of their
relationality with other people and things around them, like a network in ANT. These
relational sites become a focus of intervention by governments who seek to first understand
and then redirect people (and things) towards a particular goal via techniques and processes
of power (e.g., knowledge derived through epidemiological data collection, see Collier 2009,
pp. 86-87). The techniques of power are the tools mobilised to accumulate knowledge,
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while the processes are political rationalities employed that shape the boundaries of
thought and action for a population in a particular context (Rose, O’Malley and Valverde
2006). Political rationalities are ways of thinking about governing and how to distribute
knowledge for that purpose (Rose and Miller 1992).

Rose, O’Malley and Valverde (2006, p. 98) identify that a key criticism of governmentality
theory is the misguided “cookie-cutter typification or explanation” of a government
program as being a particular political rationality, e.g., neo-liberal. They suggest that it is
important to consider that political rationalisations are always developing and adapting. For
example, to suggest that something is neo-liberal does not demonstrate the diversity and
dynamism of neo-liberal forms across contexts, a perspective that makes the related issues
seem unsurmountable. Rather, a “good” governmentality study breaks away from the
structural perspective of the monolithic state with a “panoptic” vision over citizens, as
originally theorised by Foucault (1979). It shifts instead to a more ANT-like symmetry in
which the state is simply another actor, uniquely constituted in a web of associations drawn
together by the “convergent” power of “translation” (Callon and Latour 1981, pp. 280-281).
Translation is the way that goals are constructed and come to be understood broadly
through the same language and logic (Rose and Miller 1992). This encapsulates a move
towards the variety of authority, the multiple goals of multiple actors in network ensembles,
and the different techniques employed to reach discrete political objectives (Rose, O’Malley
and Valverde 2006, pp. 84-85). Further, governmentality highlights the constructive role of
resistance in a network, creating a more open-ended, “transformational politics” than an
analysis that simply discards resistance as a negative externality to network order (O’Malley
1996, p. 312).

As in ANT, governmentality examines the durability of the layout of actors in relation to
each other, determined by the persistence of tools used to “enrol” network actors, and their
ubiquity across the socio-technical space (Rose and Miller 1992; Latour 1990). For example,
an electronically published procedural manual, dispersed systematically across multiple
health clinics would play a stronger stabilising role than a single handwritten note. Some
tools of “enrolment” are stronger than others as they disseminate readily and persist,
arranging actors in a network based on effectively translated objectives that become
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constructed as shared interests (Rose and Miller 1992, p. 184). In this context, government
is no longer a central “State”, but is rather a “multi-centred” complex of techniques and
tools which normalise, stabilise, and immobilise networks to comply with “rules at a
distance” (Rose and Miller 1992, pp. 184-185). By combining this approach with ANT, power
imbalances, theorised as durable asymmetries between actors, can be identified and
strategies for realignment of network actors into a more equal arrangement can be
considered.

Post-Colonial Challenges in ANT
Post-colonial STS operates to dismantle the dominant imperialist model embedded in the
Modern world through critical decentring and disassembling of hegemonic epistemologies
(Saïd as cited in Anderson and Adams 2007). It is important that this is distinguished from
the dismantling of the network itself, as it is rather the organising processes that are the
target for disassembly. This approach values collaboration with “views from elsewhere”
(Anderson and Adams 2007, p. 183) to accentuate the spatialities and multi-sited nature of
knowledge production processes. Just as decolonialism intentionally challenges colonial
presuppositions and impositions in social processes and arrangements (Smith 2012), postcolonial STS highlights the need to challenge colonial functions that lead to unequal
technoscientific assemblages. In this sociological project I am consciously seeking to engage
with and elevate Indigenous perspectives, knowledges, and voices (Haynes et al. 2020). I will
demonstrate that these are vital, practical, and meaningful epistemologies, not simply
tokenistic political tools (Barnes et al. 2009, p. 444) and they demand an elevated space for
expression within the ARF/RHD network. Smith (2012) identifies the Maori context of
decolonial struggle, framing it as a critical awakening that challenges the established
hegemonies of colonial social infrastructure. This challenge mediates the possibility of
alternative thinking and action that could lead to the disruption of the status quo. Similarly,
through applying a post-colonial focus in ANT, one can integrate explicit consideration of
the historical processes embedding colonial knowledge and action in healthcare systems. By
focusing on the concerns of marginalised peoples, I hope to contribute to the disruption and
rearticulation of “racial-colonial entanglements” produced through disproportionate
consideration of biomedical knowledges across institutional spaces (Sabati 2019, p. 1061).
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ANT scholars have experienced criticism for both a lack of attention to power and for
providing unbalanced attention to the high-status personalities and grand narratives of
history; a process that has contributed to screening out the “invisible work” of
understudied, marginalised associates in a network (Star 1991, p. 29). An ANT analysis,
supplemented with governmentality and post-colonial critique, will ensure this is not the
case, bringing greater symmetry to Aboriginal and Torres Strait Islander “work” towards
resistance through diverse knowledges within the hegemonically constructed reality of
endemic ARF/RHD.

Bringing it Together
Through combining ANT, ethics of care, governmentality theory, and postcolonial studies I
will perform a unique sociological analysis of ARF/RHD in Australia. As a non-Indigenous
researcher, I do not intend to assert my findings as an ultimate solution to be imposed.
Rather, following Puig de la Bellacasa (2012), I hope to offer this unique analytical
combination as a way of thinking that may be useful in addressing some associated issues.
In the following chapters I attend to some of the ways normalisation of illness in Indigenous
communities (Haynes et al. 2021) has led to a perpetually stabilised unequal network
arrangement of ARF/RHD in Australia. In these situations of stability, power can be seen as
an effect rather than a cause in the resulting unequal arrangement between human and
non-human actors (Latour 1990). While political techniques of inertia have persisted under a
regime of regulation and standardisation, a re-evaluation of these taken-for-granted
realities could dynamise the ARF/RHD network into the future. Unequal network
arrangements are contingent on past processes yet are not inevitable (Star 1991, p. 38).
Endemic illness in Indigenous populations should not be considered normal, it is not just,
and it is not unavoidable. By looking at the ways the socio-technical elements of ARF/RHD
have been changed over time, there is less opportunity for naturalisation of chronic illness
in Aboriginal and Torres Strait Islander peoples, and more possibility for a fundamental shift
in approach that appreciates the localised concerns and knowledges of Indigenous ARF/RHD
sufferers.
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Data Tracing and Association Discovery
While remaining systematic, I have chosen to primarily adopt the ANT method of tracing the
associations of the network (Latour 2005) for my data collection. To begin, I obtained a
range of scientific and medical literature through Pubmed database searches. I used the
broad search input “Acute Rheumatic Fever and Rheumatic Heart Disease Indigenous
Australians”. This yielded 70 articles for consideration. After reading the abstracts of all
articles I removed highly specific articles that did not align with my research questions e.g.,
in-depth studies of historical Group A Strep vaccine models. In addition, I collected other
sources including sociological and policy documents to gain a holistic representation of the
socio-material complexities and fluid assemblage of the ARF/RHD network. To achieve this, I
drew on the “Document and Artefact Analysis” methodology described by Macleod et al.
(2019a, pp. 181-182) whereby I examined written sources in terms of their potential role in
the network as a tool that is created, dispersed, interpreted, and used by diverse actors. By
examining texts in this way, I developed an understanding of the prominent actors and their
durability, position, relationality, and effects in the network. I utilised reference lists from
texts to trace related sources that addressed similar issues in texts conveying the same or
differing viewpoints.

Figure 1 below is a simplified image of the three-dimensional ARF/RHD network resulting
from this mapping process which enabled me to appreciate the previously inconceivable
interconnectedness between disparate network elements (McCarthy and Martin-McDonald
2007, p. 90). This process revealed to me the extent of intellectual energy and multisectoral
efforts that have been inserted into this network, particularly over the past decade in which
the most prolific research has been produced in Australia. Through this process I have
developed a comprehensive web of information, proportionate to the confines of an
Honours thesis.
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Figure 1. A simplified image of a possible ARF/RHD network. Image generated through
mapping some of the key human and non-human elements that emerged during my
analysis. Lines connecting network elements indicate energetic network processes such as
power, knowledge, and communication. * Indicates technological nodes explained further
below.
By subjectively considering this socio-technical assemblage, I was regularly drawn in by the
gathering influence and stabilising role of various technologies involved in prevention and
treatment. I made the decision to structure my research around three technologies that I
deemed most influential or prolific. Using ANT terminology, I have called these analytical
focuses technological nodes, being conspicuous points in the network that emerge as
shaping actors. The next three chapters are based around these nodes including
benzylpenicillin G (BPG) injections, echocardiograms (ECG), and Group A Streptococcus
(Group A Strep) vaccines. While these sections are to be read linearly, it is best to consider
them as contingent and interconnected as key issues in prevention, detection and
treatment can be extracted and examined in association with other related concerns. It is
my hope that through the careful consideration of the many parts of this network,
constructed over time, real world change can be seen towards the elimination of this
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endemic illness and the accompanying systemic inequalities that have persisted for so long
in Australia.
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Chapter 3: BPG Injections – The Mainstay for Prevention or a Transitionary
Tool?

Introduction
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) almost exclusively affect
poor and marginalised peoples, often catalysing the onset of chronic cardiac diseases and
lifelong dependency on biomedical health interventions (Haynes et al. 2020). For the past 70
years benzylpenicillin G (BPG) intramuscular antibiotics injections have remained a central
intervention in the ARF/RHD network in remote Indigenous communities of Australia, used
in primary prevention of ARF, secondary prevention of RHD, and treatment of RHD-related
complications. In this chapter I highlight the ways that the predominant role of BPG
injections in contemporary ARF/RHD programs has arisen and endured through
innumerable resistances, negotiations, and consensuses flowing between actors. I will
explore some of the ways that BPG injections shift their role across disparate network
dimensions through “multiplicity” (McCarthy and Martin-McDonald 2007, pp. 86-88),
pervade across temporal network regions, are influenced by the spatiality and knowledge
systems of connected actors, and absorb a large responsibility for care in the ARF/RHD
network of Australia. I conclude with a section addressing the ways that understanding BPG
injections as a transitionary actor, rather than a mainstay of prevention, could contribute to
a socially just network rearrangement in the future.

BPG Injections and Multiplicity
Patented in 1950 by Wyeth Corporation (Wyber, Johnson and Patel 2015, p. 16), BPG
technology has not seen any distinctive change over time in terms of its action in ARF/RHD
prevention and treatment. However, the ways this actor is understood and performs various
roles is vastly different across the internally multiple dimensions of the network. In the
biological dimension, it remains a vital weapon against the continuing onslaught of bacterial
attacks, demolishing the cellular peptidoglycan barriers protecting Streptococcus pyogenes,
and slowing its infective advance through bodily tissues (Wyber et al. 2016). BPG injection is
specifically designed to persist in the body of infected people, slowly releasing its germicidal
defences to ensure a multi-wave, prolonged battle against Group A Strep over several
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weeks through its low solubility in blood (Wyber, Johnson and Patel 2015). Despite a
growing tide of antibiotic resistance in the contemporary era of medicine (Bowen et al.
2014), BPG has held strong, continuing to demonstrate high efficacy in the antimicrobial
field (Currie 2006), solidifying its enduring relevance in the medical dimension of the
ARF/RHD network.

BPG injection syringes comprise of an innocuous glass cabin connected to a protrusive steel
spike, awaiting deep insertion into the gluteal muscle of a Group A Strep-infected patient by
practiced clinical hands (Pfizer 2021, p. 10). The content of BPG injections have “a high
concentration of suspended material” making a slow injection rate essential to avoid
blockages (Pfizer 2021, p. 2) and severe pain (Mitchell et al. 2018, p. 46). At the same time
and less tangibly, they are a lifesaving medium of antimicrobial defence, arising through
their inextricable association with remote Indigenous ARF/RHD patients. The current
arrangement of these actors in the network are contingent and interdependent: without
BPG injections, a genetically susceptible ARF/RHD patient in a high-prevalence area remains
vulnerable to repeated auto-immune attacks and chronic illness. Without the patient
requiring treatment, a BPG syringe is simply a spiked vial of industrially reconstituted mould.

When these elements align through the act of clinical injection, a hybrid association is
formed between human and non-human elements of the network. For example, individuals
diagnosed with ARF are prescribed with injections of BPG every 28 days for up to ten years
(Haynes et al. 2020). Through these durable connections, BPG injections remain prominent
in the mainstream biomedical fight against Group A Strep and subsequent ARF/RHD. The
biomedical view of BPG injection, conveyed widely in scientific, medical, and political
arenas, formulates this tool as a central element in addressing this crisis of preventable
illness (Dooley et al. 2021; Australian Institute of Health and Welfare 2019). By stepping into
the scene of prevention and treatment, BPG injections assume the role of an immune agent;
a role that in low-risk patients would generally be performed by their innate and adaptive
immune systems, without any need for biomedical intervention.
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A Painful Interaction
The human/non-human hybridity formed through BPG injection of remote Indigenous
patients is problematized by the physical pain of the interaction. The procedure is known to
injure in the absence of effective pain management, and sometimes symptoms of
unwellness can persist for days, leading some patients to be fearful of this clinical
interaction and avoid it (Amgarth-Duff et al. 2019; Mitchell et al. 2018). RHD Australia, a
Department of Health funded multi-sectoral agency, in cooperation with the Aboriginal
Health Council of South Australia, developed a brief visual guide for healthcare workers to
highlight the appropriate preparation, application, and care required in a BPG injection
interaction (Figure 2). This visual tool signals to educators and healthcare workers that BPG
is a key intervention for people with ARF/RHD. Concurrently, it stresses the potential to
cause distress or pain where the clinical application is performed without care and
consideration. However, the onus of ensuring appropriate BPG injection administration is
sometimes shifted into the patient dimension of the ARF/RHD sufferer and their family. The
partial transference of responsibility for this clinical procedure is apparent in the patient
information provided by the South Australian Government (Figure 3). This advises the best
ways for patients and families to approach health staff to ensure appropriate clinical pain
management techniques are applied. These two figures engage with BPG injection
procedures across disparate dimensions of the network indicating to both health staff and
patients that this crucial experience can be painful. Concurrently, they communicate to
disparate actors that with effective and respectful interpersonal communication of a shared
interest to minimise pain this life-saving interaction can be less burdensome.
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Figure 2. Guide to administering
penicillin (BPG/Bicillin/LAB). Poster
developed by RHDAustralia and the
Aboriginal Health Council of South
Australia Ltd. outlining summarised
recommendations for administration of
penicillin antibiotic injections by health
practitioners. Available online from:
https://www.rhdaustralia.org.au/resour
ces/guide-administering-penicillinbpgbicillinlab

Figure 3. Rheumatic Fever and Penicillin Injections: How to reduce pain. Poster developed
by RHDAustralia and the Government of South Australia outlining patient communication
tools for discussing pain management of BPG injections with health staff. Available online
from: https://www.rhdaustralia.org.au/resources/rheumatic-fever-and-penicillin-injectionshow-reduce-pain-patients
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This BPG injection-clinician-patient-family nexus of the ARF/RHD network highlights complex
relationality and multiplicity at a single socio-material interface. Examination of official
educational resources (Figure 2 and 3) illuminates an area of the network where power
differentials between predominantly white health staff and Indigenous patients have
manifested in ARF/RHD health settings. In clinical settings poor adherence to long-term
antibiotic programs is often attributed to individual patient non-compliance (Harrington et
al. 2006). In parallel, Haynes et al. (2020) identify the theme of “collective trauma” in their
systematic review of literature that attends to Indigenous experiences of ARF/RHD. They
identify that “collective trauma” is sensed through processes of racism, fear, and anger in
various culturally insensitive interactions with non-Indigenous health staff and institutions
(p. 10). This emergent critique from academic actors exemplifies the complexities of the
injection-patient interaction, beyond just physical pain, and highlights the difficulties arising
from misapplication of biomedical models in Indigenous healthcare. While it is yet to
translate into official health policy (Haynes et al. 2021, p. 2), this critique is developing as a
key destabilising knowledge system in the ARF/RHD socio-technical space. Through inclusion
in new national guidelines and strategies (Wyber et al. 2020; RHDAustralia 2020), this social
justice narrative is operating in opposition to the “business as usual” biomedical approach
(Welch et al. 2020, p. 119) that continues to dominate knowledge flows in the ARF/RHD
network.

The multiple identities of BPG injections across disparate ARF/RHD network dimensions
highlights the ways that this one non-human actor is materially and functionally malleable,
depending on who or what it is interacting with. While some actors see poor injection
adherence as a complex experience of health injustice, others see the inadequacies of BPG
programs as a procedural issue with implementation and patient engagement that can be
optimised through education. By shifting between actor viewpoints, it is apparent that
whilst the biomedical vision of bodily health and clinical efficiency is an integral part of
addressing Group A Strep-related illness, complementary consideration of the sociohistorical and political implications of hegemonic methods in healthcare is essential for a
well-rounded perspective. Aligning these parallel views could be immensely beneficial to
dislodging the health inequality of ARF/RHD via the driving energies of communication for a
result of collaborative medical-patient hybridities. Øversveen (2020, p. 862) highlights the
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potential of some health technologies to enhance existing and persisting health inequalities
for those who are unable to “materialise and enforce institutional expectations” for the use
of these healthcare approaches. I believe that BPG injections could move away from being
seen as a matter of patient non-compliance in an exclusionary health system. Rather, its role
could be shifted towards a community-owned tool of protection, in better grouping with
Indigenous ways of being and doing than with biomedical knowledges that see it as an
isolated clinical tool to be used on and by Indigenous peoples in prescriptive ways.

Effectiveness of BPG Injections Across Space and Time
BPG injections are generally considered both clinically- and cost-effective against endemic
Group A Strep infections (Hardie, Ralph and de Dassel 2020). However, this scientifically
reliable actor is often unable to deliver in its pivotal public health role for ARF/RHD
prevention in the field, shown by ever-increasing case numbers despite its widespread
implementation (Katzenellenbogen et al. 2020; Health Policy Analysis 2017). Its success is
entirely contingent on coordination and interdependence with other network elements,
many of which reject its constructed status as the solve-all solution to endemic chronic
illness.

BPG injections are employed across all temporal stages of ARF/RHD disease progression in
remote communities including primary, secondary, and tertiary prevention. To achieve this
multi-stage dispersal and implementation involves the circulation of immense network
energies (Latour 2005, p. 17). These energies, in particular communication, flow through the
network spaces, acting to renegotiate pre-established healthcare and community roles in
order to mobilise BPG injections across policy writing, medical practice, and patient
education. For example, studies have identified Group A Strep skin infections can be treated
with 80% efficiency through a single BPG injection as a form of primary prevention (Wyber
et al. 2021); secondary prevention can be systematically implemented on a routine basis
when coupled with active diagnosis of ARF/RHD using an echocardiogram (ECG) (Ralph et al.
2020); and tertiary prevention of complications relating to valve surgery, such as infective
endocarditis, can be reduced through patient BPG injection adherence (Australian Institute
of Health and Welfare 2019). Through activation across all temporal stages of disease in the
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ARF/RHD network, BPG injections are imbued with an inordinate responsibility for care in
ensuring the avoidance of chronic heart illnesses in contexts that have historically been
systemically neglected and excluded by government institutions and health services (Bond
et al. 2020).

The multi-sited temporalities of BPG injection places an excessive socio-political and
historical load onto a small mould-filled-case-with-a-needle. One way in which BPG
injections manage this load is through sharing accountability for care across network
associates, thereby maintaining its elevated status in prevention and treatment. This sharing
of responsibility is achieved via processes of translation. For example, BPG injections are
linked to RHDAustralia, a government ensemble that has developed and dispersed huge
volumes of educational resources including: procedures, guides, flow charts, posters, songs,
videos, and smart phone applications relating to BPG injection (RHDAustralia 2021). An
example of these resources is the short film entitled Important Health Message: prevent
rheumatic fever (Moonshine Agency Pty Ltd 2014). This video is accessible in eleven
Aboriginal and Torres Strait Islander languages and English and positions BPG injections as a
necessary medication to “keep your heart good” and that “will stop rheumatic heart coming
back” (Moonshine Agency Pty Ltd 2014). This wide range of resources and their diverse
target audiences highlights the potential for heterogenous actors from disparate social,
cultural, and geographical locations to be brought into closer association with BPG injection
as a positive health actor. These knowledge tools and processes, stemming from BPG
injections, have a gathering effect. They each draw on the empirically proven yet limited
impacts of this actor’s biological and practical effectiveness in preventing RHD, and translate
it across network regions via communicational processes, such as local languages, to
increase their coherence and accessibility.

But somehow all these energy flows and attempts to convince connecting actors of the
centrality of BPG injections do not result in ARF/RHD reduction. In ARF/RHD, health
professionals often fail to follow recommended procedures due to poor training or a
restrictive scope of practice (Harbridge 2016). Additionally, patients are unable to engage
with technologies due to a suite of complementarity issues, similar to what Øversveen
(2020) finds in the case of diabetes. Some of the complementarity issues contributing to this
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disengagement include experiences of racism, pain, inaccessibility, or trauma (Haynes et al.
2020). Further, public funds do not address resourcing gaps that are essential for effective
BPG program implementation across many diverse communities (Wyber et al. 2020, p. 10).
Therefore, communication has a gathering effect to an extent, but the longevity of this
coherence between actors is strongly influenced by the quality and reciprocity of the
content. This concept is encapsulated by Jennings et al.’s (2018, p. 114) idea of “good caring
talk” which highlights the way translations are understood and accepted by surrounding
network associates in their own terms and not forcibly imposed from the outside in. In
particular, Indigenous community acceptance of healthcare programs, such as BPG
injections, is influenced by the ability of health professionals to display “respect and care for
its Indigenous clients as human beings” (Jennings, Bond and Hill 2018, p. 114) and through
self-reflection upon the shared colonial experience of Indigenous peoples in healthcare
settings (Mitchell et al. 2021, p. 50).

The space for positive engagement in the network can be proactively facilitated through
culturally appropriate outreach. A recent study by Hardie, Ralph and de Dassel (2020, p.
427) demonstrated that “in the NT, 76% of people diagnosed with RHD between 2014 and
2018 had no previous ARF diagnosis” and so community members were never given the
option of receiving preventative BPG injections. Even so, BPG injections are held in place by
health professionals as the principal element of primary, secondary, and tertiary prevention,
against the advice of researchers who suggest a more holistic, engaged, and collaborative
approach is necessary (Wyber et al. 2020; Hardie, Ralph and de Dassel 2020). In the face of a
growing body of evidence, BPG injection continues to stand out from the surrounding
elements through its durable ubiquity across prevention and treatment. This is despite
surrounding actors challenging its ongoing significance by exposing its real-world
insufficiencies (Hardie, Ralph and de Dassel 2020). Breaking down peptidoglycan cell walls of
Group A Strep is an amazing biological feat. However, breaking down the systemic health
inequalities leading to embedded ARF/RHD in remote Indigenous Australia requires
proactive reciprocity and respect for difference, beyond the scope of a needle.
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Changing Materialities and Intermittent Commitment
The application of BPG injections in remote communities is an immensely resource intensive
project that demands economic investment, professional commitment, and community
collaboration for its effective implementation (Wyber et al. 2020). Investments of time,
money, and passion from various groups and individuals to ensure suitable administration of
BPG to Aboriginal and Torres Strait Islander peoples have been only intermittently
successful. This is due to various concerns such as poor healthcare delivery, failed
community education projects, and diagnostic limitations (Hardie, Ralph and de Dassel
2020). These existing concerns are compounded further in periods of short supply of BPG
(Wyber, Johnson and Patel 2015). Stock-out periods have occurred at least five times since
1995 and relate to shifts in corporate ownership and the associated movement of factory
locations for production and distribution (Wyber et al. 2016, p. 21). These interruptions
signal that, historically, BPG injections have not been stable enough to meet constant care
requirements for effective prevention and treatment of ARF/RHD. It highlights that BPG
injections are subject to outside influence and their appearance in the network is somewhat
sporadic, demonstrated by material shifts over time: from a powder-based formula
delivered via a “horse syringe”, to a smaller liquid injector, to occasional absences in the
early 2000s that led to usage of a painful and problematic powder once again, and finally
returning in the small liquid Bicillin L-A formulation that is now produced in Australia and
owned by Pfizer Incorporated (Wyber, Johnson and Patel 2015; Currie 2006). The recent
shift to local production of BPG injections by Pfizer has been beneficial, as shown by shorter
interruptions that were more effectively managed (Wyber, Johnson and Patel, 2015).
However, changeable material compositions accentuate that the success and stability of
BPG injections is not only dependent on local conditions of clinical administration and
patient adherence. It is also reliant on far-off corporate processes that do not always
appreciate the need for constant BPG allocation to remote areas when economic and
business imperatives dictate otherwise (Currie 2006).

The role of BPG injections in fighting Group A Strep infections remains important to
ARF/RHD prevention and treatment, yet there is no recourse for periods of absence. Semiregular shortages position BPG injection technology as an outside actor; its supply is derived
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through processes external to the communities it is used in, and its production is owned by
economically dominant actors that are somewhat disassociated from the needs of the
people they are distributing medicines to (Currie 2006). Currently, the only active method of
preventing development of ARF/RHD in Australia is dependent upon the actions of a single
company and their corporate commitment to “empowering and equipping” (Pfizer 2020, p.
6) patients in their ongoing monopoly of BPG injection products. While their Corporate
Social Responsibility slogan, “Pfizer CARES”, seems to align with this goal, perhaps the sociopolitical distance of any corporate ensemble from the lives of remote Indigenous patients is
too great to overcome. If Pfizer Incorporated were to follow the recent historical pattern
and shift their proclaimed responsibility of care for Indigenous remote patients on to
another company, will the supply be interrupted again? For how long? As Wyber, Johnson
and Patel (2015, p. 508) suggest, diversification of local suppliers and increasing
transparency of supply communication could protect against these dislocations. However,
the continuing reliance on BPG injection is not likely to eliminate ARF/RHD in Australia while
ever extreme health inequalities persist (May, Bowen and Carapetis 2016).

By targeting the social determinants of health and raising standards of living to a level equal
to that of other Australians, ARF/RHD could be effectively prevented along with a suite of
other illnesses relating to the profound disadvantage of Indigenous Australians (Hardie,
Ralph and de Dassel 2020). This could be achieved by enhancing the capacity of
communities to establish ownership of the means to provide and share care to core
network elements that are most greatly impacted by a sustained, responsible commitment
to the health of Indigenous peoples (Carapetis and Brown 2020, p. 116). This does not
preclude biomedical and corporate actors, but it does reduce their prominence and disperse
their source of power throughout the network configuration. It is a demonstrably
unsustainable practice to place all the responsibility for BPG supply on a single, historically
fickle corporate assemblage. Through a gradual realignment of network energy flows via a
coordinated long-term commitment to social justice, it may be possible to diversify BPG
suppliers and enhance its reliable availability across remote Indigenous communities longterm.
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Conclusion
To close this chapter I return to Puig de Bellacasa’s (2011) concept of care as a dedicated
“ethico-political” commitment to “matters of concern”, such as endemic ARF/RHD in
remote Indigenous Australia. Through this examination of BPG injections I do not wish to
diminish the role of this antibiotic actor in the broader network. My intention is rather to
expose some of the contingent processes that have led to the ineffective elevation of this
biomedical tool above the many other diverse elements that hold the capacity to mobilise
care in unique, dispersed and coordinated ways. ARF/RHD is a social justice issue as it is
preventable via the manipulation of social determinants of health that could culminate in a
healthy, safe, and secure environment where people are able to thrive. Instead, biomedical
streams of knowledge and power stabilise the elements of the network that address the
aftermath of inequality rather than the cumulative impacts of social, economic, political,
and historical processes that have led to disadvantage in the first place. Prolific, durable,
and systemic implementation of BPG injections is only required where endemic Group A
Strep and other bacterial infections are widespread. By drawing on the existing relational
power that pervades Indigenous communities, the respectful, reciprocal, and proportionate
integration of BPG injections as a protective tool of care could be much more successful.
Instead of acting as the temporal, spatial and political mainstay of ARF/RHD elimination,
BPG injections could become a far more collaborative actor. They could become realigned
as an integral yet transitionary tool for Indigenous-led eradication of ARF/RHD by bolstering
the health outcomes of communities while primordial prevention projects that address the
root causes of health inequality are elevated as the priority.
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Chapter 4: Echocardiogram –Visiblisation and De-Professionalisation?
Introduction
Echocardiograms (ECGs) are an ultrasound machine that converts sound bouncing off
internal bodily structures into two dimensional (2D) images via a transducer wand. ECGs are
an important technology for the diagnosis of ARF/RHD as they provide the means for
viewing the internal structures of the heart that are otherwise unobservable. They are
closely linked with BPG injections in the ARF/RHD network as they are used on people with a
history of Group A Strep infection and to diagnose new ARF/RHD patients that then require
antibiotics. While ECGs extend out from the ARF/RHD network of Australia in many ways,
their controversial stabilisation as a technological node is contested by many actors. In this
chapter I explore network discourses regarding ECGs to show the ways that the “potential
and power of a technological device to shape an interaction is not pre-given but is realised
in practice” (Timmermans 1998, p. 148). I consider how ECGs are ordered by techniques of
standardisation that simultaneously visiblise and exclude actor groups, and the ways that
ECGs are a professionalised tool associated with jurisdictional network boundaries in
remote settings. I conclude by proposing that the standardised expert use of ECGs has
played a key role in visiblising remote communities, and that de-professionalisation of
diagnostic criteria could work to shift the network towards localised health management
practices in the ARF/RHD network.

ECGs and Socio-Technical Exclusions
ECGs were developed into a medical tool for observation of heart valve disease in the 1950s
(Krishnamoorthy, Sengupta and Khanderia 2007). Since ECGs were combined with colourDoppler velocity imaging, developed in the 1980s, the direction and speed of flows of blood
are also observable (Krishnamoorthy, Sengupta and Khanderia 2007). The use of ECGs has
the potential to enhance the sensitivity of detection techniques for earlier treatment of
ARF/RHD via a hybrid interaction of human technicians and non-human machine actors.
Through active case finding programs (Francis et al. 2020) and subsequent diagnoses based
on appropriately specific criteria, persons with ARF/RHD can be placed on registers,
prescribed with antibiotics, monitored for disease progression, and referred to hospital for
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life-extending surgical procedures. Importantly, the systematic enrolment of ECGs as either
diagnostic, preventative, or both, is dependent upon network stability and acceptance of
this technology, driven by energies that lead to consensus.

The nodal role of ECGs as a screening device has been elevated by multidisciplinary actors in
the ARF/RHD network timeline over the last decade through durable network processes of
enrolment. Revisions to both the Jones Criteria for ARF diagnosis by Gewitz et al. (2015) and
the World Heart Foundation (WHF) criteria for ECG screening by Remenyi et al. (2012) have
been influential in establishing new roles for the ECG, negotiating existing socio-technical
relations in the network space. These criteria have been enrolled into the network by
advocates through processes of lobbying, research, and persuasion to better encompass the
endemic nature of ARF/RHD burdens in low-income regions of the world. These revisions
reflect a shift in the official health narrative towards greater inclusion of the experiences of
remote Indigenous communities. As official narratives often operate as an expression of the
political rationalities of government ensembles (Latour as cited in Rose and Miller 1992, p.
183), these criteria exemplify the ways it “is often in the seemingly ‘technical’ matters that
deeply relevant, social issues are ‘hidden’ – such as inclusion/exclusions of certain groups or
voices, or the subtle restructuring of patients’ or professionals’ identities” (Timmermans and
Berg 2003, p. 108). While previously only used to confirm clinically detectable cases, the
shifting network arrangement mobilised by these revisions indicates the increasing
importance of ECGs in visiblising under-recognised illness in remote Indigenous
communities of Australia.

The Jones Criteria for ARF Diagnosis
The presentation of ARF/RHD in low resource settings differs greatly from established norms
of disease progression observed in high resource settings (Steer 2015). I will argue here that
differences across the multiple worlds of a network means standardisation and rules act as a
source of order through “sameness and stability for many people”, whilst being a source of
“chaos and trouble” for those that do not conform (Star 1991, pp. 41-42). The differences in
disease manifestation across contexts demands a level of sensitivity in diagnostic
assessments that reflects the heavier burden of ARF/RHD in some communities. That is,
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assessments must be sensitive to the reality that disease is probable in high prevalence
regions. Prior to the 2015 revision of the Jones Criteria, diagnostic attention was directed to
high-income areas with low prevalence of ARF/RHD by health officials. The clinical focus on
non-endemic areas drove the development and dispersal of specific diagnostic standards
that were geared towards the improbability of ARF/RHD, unless a person had experienced
preceding Group A Strep infection. The specificity integrated into these diagnostic criteria
assumed that case numbers of ARF/RHD are low (as they are in high resource settings), so
the standards became more restricted to avoid over-diagnosis of a largely declining illness
(Beaton and Carapetis 2015, p. 7).

Through standardising knowledge processes, applied universally, the Jones Criteria
contributed to the “effacement” (Prout 1996) of the high prevalence network regions with
endemic ARF/RHD, including remote Indigenous communities of Australia and, more
broadly, people of the Global South. Effacement is a network effect whereby some actors or
ensembles, such as remote Indigenous communities, are isolated as a separate entity and
made invisible to associated elements, rather than viewed as a contingent network
component with related concerns (p. 201). This allows other regions of the network to
function and flow uninterrupted, yet sometimes these invisible regions become visible,
often when a key technology fails. In Australia, an assumption of low probability of ARF/RHD
was not transferable to endemic regions and left people with sub-clinical illness
undiagnosed through insensitive, highly specific measures of contextually inappropriate
standards. Through this failure to prevent disease with existing criteria, some actors worked
to re-introduce the high-prevalence network region into the mainstream agenda.

In Australia and New Zealand, inappropriate standards meant the replacement of the pre2015 Jones Criteria with a unique set of diagnostic criteria in 2012 (Beaton and Carapetis
2015, p. 7). This bespoke set of national guidelines, relevant to the needs of diagnosing
Indigenous peoples in remote areas, was a meaningful shift away from universalising
historical standards. The previously convergent effects of the Jones Criteria as a translative
device began losing traction and relevance in the network due to its localised
appropriateness to non-endemic regions and its neglect of high prevalence areas. Actor
opinions began to shift and the network’s fluid propensity for change was revealed through
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adaption to new risk-stratified techniques of diagnosis that were more contextually
appropriate to remote Indigenous communities and their experiences of disease.

In 2015, Gewitz et al. (2015) revised the Jones Criteria to incorporate ECGs as a crucial tool
for detecting carditis for ARF diagnosis in high-risk populations. The significance of this
revision is far-reaching as it encapsulates a network consensus on the validity of sub-clinical
or under-recognised manifestations of disease that were previously a contested area of
research. The dispersal of this new criterion exemplifies a “process of translating the images
and concerns of one world into that of another, and then disciplining or maintaining that
translation in order to stabilize a powerful network” (Star 1991, p. 32). In this case an image
of ARF/RHD was translated from the world of researchers concerned with endemic disease
in the communities of marginalised peoples, into the global health sphere.

However, while the 2015 criteria are more inclusive of remote Indigenous disease trends,
the setting of standardised boundaries excludes the multiple lived experiences across a
network that could never be fully captured in an homogenous format, such as criteria (Star
1991, p. 36). The criteria remain a normative prescription of potential presentations of
ARF/RHD in endemic zones and could potentially exclude patients that fall outside these
biomedically dictated patterns of disease expression. For example, an Indigenous patient
from a moderate-high risk population that presents to a clinic with only the symptoms of
carditis and a fever of 37.9C does not meet the criteria for an initial diagnosis of ARF under
this model. There are currently no additional tests available that would enrol this person
into the network as an ARF patient as they did not have enough symptoms that match up
with prescribed combinations of observable pathologies. However, this may change in the
future through biotechnological developments such as the identification of biomarkers
specific to ARF (RHDAustralia 2020, p. 287). This area of scientific research highlights the
ways that “Standards can stabilize some actions in a moving world, but when the world
around the standard changes, the standard will quickly become outdated or altered as well”
(Timmermans and Epstein 2010, p. 84). While increased sensitivity in the Jones Criteria and
use of ECGs have improved case ascertainment for Indigenous peoples, there remains
potential for cases to be missed via exclusive and standardising techniques. Despite the
continuing potential exclusion of non-standard cases, the 2015 criteria revision has meant a
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temporary stabilisation around new normative claims of ARF diagnosability and the integral
role of ECGs in this process.

The WHF Criteria for RHD Diagnosis
In their 2012 revision of the World Heart Foundation (WHF) criteria for ECG diagnosis of
RHD, Remenyi et al. (2012, p. 297) identify that the use of auscultation (listening with a
stethoscope) as a method of carditis detection has led to underdiagnosis of many “silent or
undetected attacks” of ARF/RHD. They demonstrate that the incorporation of ECG screening
in high-risk areas would greatly increase the potential to intervene and treat people with
sub-clinical manifestations of disease more readily, and thus reduce the economic and
resource burdens of associated surgeries and acute care for advanced disease. Through this
research these authors sought to rearrange and dislocate the elevated significance of
auscultation in the ARF/RHD network through dispersal of new and influential criteria,
highlighting the significance of sub-clinical diagnosis with ECGs.

Some clinical and research actors resisted this narrative; suggesting that the successful
integration of ECG screening for the diagnosis of latent disease is contingent upon the
development of robust BPG injection programs and broader health service delivery
improvements in remote areas (Remond, Wark and Maguire 2013). These actors challenged
the widescale integration of ECG screening as a diagnostic mainstay, attempting to shift
network energy back towards existing BPG injection programs that remain inefficient and
under-resourced. Hempenstall et al. (2021) raise related concerns derived from their ECG
screening study of Torres Strait Islander children. In their study, the ECG emerged as a
revelatory tool of “missed opportunities” for prevention of ARF/RHD as it exposed many
previously unknown cases, while also highlighting the sub-optimal health service delivery,
lack of antibiotics prescribed to patients presenting with symptoms in endemic regions, and
poor access to dispersed populations of people for screening (p. 1211). Without associated
system-wide improvements, this network ensemble of resistant research actors propose
that the implementation of ECG screening is immutably dependent on the success of other
evidence-based prevention programs, such as antibiotic administration, that have
repeatedly failed in practice.
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Despite this cautionary discourse, the need to identify sub-clinical ARF/RHD has been a
growing area of interest, supported by the emergence of the WHF criteria in 2012. Subclinical carditis has been demonstrated as a significant manifestation of disease through an
expanding suite of medical evidence and knowledge about ARF and its subsequent
development into chronic RHD when left untreated (Watkins et al. 2018), yet “the power of
standardization depends on whether standards are actually implemented” (Timmermans
and Epstein 2010, p. 79). Through their research, pro-ECG actor groups have mobilised their
professional and technical capacity to further stabilise the role of the WHF criteria in
empirical research examples. While issues with preventative antibiotic administration and
resource shortages persist in remote areas, these research actors have reinforced the
importance of the ECG as a tool to prevent unnecessary disease progression through active
interception of cases (Francis et al. 2020). While BPG injections are largely considered the
only cost-effective approach to ARF/RHD prevention, Roberts et al. (2017) modelled several
approaches to demonstrate cost-effectiveness of ECG screening. Their study included 80
different remote Indigenous communities in the NT and showed that comprehensive
screening rotations by a small team of highly mobile ECG experts in remote areas could
achieve substantial monetary savings by identifying RHD cases one to three years earlier
than they are currently. In concurrence with this view, Francis et al. (2020) promote the
substantial benefits of pro-active asymptomatic detection of ARF/RHD, uncovering “an
unprecedented burden of undiagnosed RHD” in their study based in a single remote
community of the NT. These various approaches demonstrated the cost-effectiveness of
ECGs and their useful alignment with the 2012 WHF criteria as the new gold standard for
RHD diagnosis.

Professionalisation and Readjusting Boundaries
While contested in many ways and often unavailable for use where they are most needed,
ECGs perform as an invaluable tool of visiblisation, superseding the role of the stethoscope
as the official instrument for detection and diagnosis in the ARF/RHD network. However, in
remote Indigenous communities of Australia, their rarity means they remain somewhat
dissociated in practice, withheld from these areas by economic and professional barriers. In
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many of these remote communities, ECGs are a passive tool of confirmation, used where a
patient with suspected RHD, identified by auscultation, is transferred to regional clinics offCountry to have their clinical diagnosis confirmed by ECG technicians (Walsh and
Kangaharan 2017). ECGs are generally a specialty piece of equipment in this association,
managed by a team of multidisciplinary experts that are qualified to diagnose patients
through interpretation of ECG-Doppler colour imagery (Francis et al. 2020). The restricted
access and expertise involved in ECG operation is indicative of processes of
professionalisation in the ARF/RHD network.

Professionalisation of ECG operation demarcates the practice of ARF/RHD diagnosis as a
separated expertise that has arisen alongside the ECG as a diagnostic technology. The result
of such “jurisdictional claims” to expert knowledge and practice is often struggle (Abbott as
cited in Pickard 2010, p. 1074); struggle to maintain a legitimate position as an expert, or a
struggle to de-professionalise a particular role by destabilising and shifting network
boundaries. Despite updated criteria prescribing ECG diagnosis, the technical knowledge
and qualifications generally required to perform scans and interpret images mean that in
low-resource, high prevalence ARF/RHD areas, the use of ECGs is restricted or non-existent.
The network connections of ECGs to remote regions remains largely a technical
recommendation rather than a lived reality for many Indigenous peoples. However, these
boundaries are beginning to shift.

In remote settings, the professionalised status of an echocardiographer as a medical
specialist is problematic due to the reduced capacity of local healthcare workers to perform
diagnoses on-site and progress to the prescription of BPG antibiotics where appropriate
(Harbridge 2016). Bicudo de Castro (2020, p. 471) identifies that professionalisation
processes in an actor-network are heterogenous, undertaken by diverse actors with various
goals, strategies, and outcomes that either weaken or support certain activities, such as
non-expert echocardiography in ARF/RHD diagnosis. When the practical and material
aspects of the machine-human interaction of ECG screening are broken down into
constitutive elements, there seems to be insufficient reason for such selective operation of
this imaging technology. Any healthcare actor trained in the use of a transthoracic ECG
could, in theory, use an ECG machine. The difficulties arise in the interpretation of images
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collected and the technology available. When compared to a healthy heart (Figure 4 a, b),
“definite RHD” cases (Figure 4 c, d) have clearly defined features in the WHF criteria and the
differences in morphology and function are pronounced on an ECG-Doppler image.
However, these pathologies signify two possible points on a continuum of disease and
health and the ability to obtain a clear image is heavily dependent on the quality of the
machine itself, not only on the person operating it. For example, employing handheld
portable devices results in much lower detection rates for borderline RHD, “even by
experts” (Watkins et al. 2018, p. 1403). The failure to diagnose ambiguous cases is then, not
an issue for experts vs non-experts, but is rather a contingent issue that occurs in materially
disadvantaged settings that cannot afford high-end machines.
a)

c)

b)

d)

Figure 4. Echocardiogram images collected by echocardiographer Ben Reeves showing
patient with healthy heart vs patient with valvular regurgitation due to rheumatic heart
disease (RHD). a) Healthy heart with long smooth valve structure upon opening b) Healthy
heart with closed mitral valves and minimal regurgitation detectable via Doppler colour
imaging c) Definite RHD affected heart with damaged mitral valves upon opening indicated
by nodules on ends of valve leaflets d) definite RHD heart with mitral valves closed and high
levels of regurgitation detected via Doppler colour imaging. Images available from:
https://www.rhdaustralia.org.au/resources/echocardiography-rheumatic-heart-diseaseben-reeves
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In response to the increasing availability of affordable, portable ECG technology there has
been growing interest in the de-professionalisation of ECG imaging to shift network
boundaries away from dislocated technical staff and towards local empowerment of
communities through ownership of health management activities. In a recent government
evaluation of echocardiography for detection of heart failure and RHD, some of the key
recommendations were to ensure the ECG is performed close to a person’s home and in a
timely manner (Australian Institute of Health and Welfare 2020, p. 15). However, there is no
dependable supply of trained technical staff or ECG machines in remote clinics and other
low resource regions to enable such an intention to manifest in practice (Watkins et al.
2018, p. 1403). By training “non-expert screening personnel” in a simplified approach to ECG
examinations on portable devices, Francis et al. (2020, p. 121) infer there is potential for
more efficient use of this technology in high-prevalence areas that could benefit immensely
from early intervention. This viewpoint arose in response to the professionalised exclusivity
found in the 2012 WHF criteria that is geared towards experts using quality machines in
clinical settings (Watkins et al. 2018, p. 1403). Evidence-based guidelines are an example of
the ways that expert work is becoming increasingly organised through processes of
standardisation (Timmermans and Berg 2003, p. 109). This has been an ongoing barrier to
effective integration of ECGs across the ARF/RHD network conformation and Watkins et al.
(2018) suggest there is a need to create abbreviated screening criteria. Introduction of
simplified standardisation would contribute to a de-professionalisation process that repositions distinctive expert boundaries of the network, enhancing efficiency and ubiquity of
the technology through a growing association with non-expert operators (Petrakaki, Barber
and Waring 2012, p. 430).

Globally, RHD is one of the most underfunded and under-resourced areas of public health in
relation to its health burden (Macleod et al. 2019b). As a materially neglected health
concern, several network actors have performed investigations into the potential for more
widespread ECG use within remote and low-income areas. In any heterogenous network
space, translation is a crucial process that aligns disparate elements, asserts professional
boundaries, or moves them into new locations through standardising tools (Star and
Griesemer 1989, p. 404). These standards coordinate action in a network as they set shared
expectations, when communicated effectively, across network dimensions. Facilitated by
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the Telethon Kids Institute, the focused cardiac ultrasound (FoCUS) screening project
explored the feasibility of training non-experts in ECG operation to increase access to these
devices in low-resource, high-risk areas of Fiji (Engelman et al. 2016). The training involved
an eight-week program for the detection of mitral and aortic regurgitation. The results
demonstrated high levels of sensitivity, specificity, and accurate diagnosis of RHD using
simplified criteria. These were promising results; however, they are ungeneralisable to
contexts in the Torres Strait and mainland Australia without local research. In 2018 a nonexpert ECG study was performed in Maningrida, NT by Francis et al. (2021). In this study,
local health workers were trained in an abbreviated approach to echocardiography. This
training was delivered in English for six days and, like FoCUS, involved identification of
regurgitation as a key pathology of RHD. This study showed high sensitivity and specificity;
however, the accuracy was not as high as desired by investigators. These technical,
community, and non-expert actor groups demonstrated the ways that technologies and
their related guidelines are fluid and adaptable, seen through shifting boundaries of
professionalisation and de-professionalisation. Standards have been adapted with varying
success across non-expert studies, highlighting the potential flexibility of the
professionalised boundaries of ECG use in low-resource settings into the future.

Conclusion
The successful implementation of ECGs as a technological node has been an area of
controversy due to unknown benefits in the detection of sub-clinical RHD. Additionally, the
expense of supplying specialised machines and people to low-resource, remote settings has
been a major barrier to ubiquitous ECG use in prevention. Despite these concerns, research
into the benefits of sub-clinical diagnoses and the emergence of more affordable portable
machines have allayed many of these fears and ECGs have been integrated into the network
through standardised expert criteria for use in diagnosis. The remaining concerns largely
surround network access to this sought-after preventative tool and its successful
implementation across diverse communities, currently restricted by professionalised
boundaries and poor-quality machines where available at all. Through consideration of
recent studies, the potential to train local health workers to manage screening protocols
could re-align these network boundaries, mediated through the translative effects of
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simplified standards for diagnosis. This process of de-professionalisation could reduce
reliance on distant technicians and reassert community ownership of health outcomes
through localised screening programs run by local health workers.
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Chapter 5: Group A Strep Vaccine - A ‘Game-Changing’ Solution?

Introduction
In 2019 the World Health Organisation (WHO) released an “actionable framework for
vaccine development”, aimed towards mobilisation of a global campaign to bring a Group A
Strep vaccine into being (Vekemans et al. 2019, p. 877). Two years later, I explore the
network processes that have led to the dynamic integration of Group A Strep vaccines as a
technological node in the ARF/RHD network of Australia over time. This vaccine technology
has not been developed into a safe product for human use, nonetheless, it remains a central
promissory actor that drives funding, decision-making, and carries the hopes for future
eradication of ARF/RHD globally. In this chapter I examine vaccine development by
attending to the materialities of Group A Strep bacterium, exploring the discursive evolution
of vaccine development in Australia, and reflecting on the ways that the configuration of a
network, while sometimes temporarily stabilised, is flexible and dynamic. I conclude by
arguing that retrospective consideration of network actor discourses reveals changing
perspectives over time and subsequently exposes opportunities for network shifts to be
imagined as a contingent evolution of ideas for socially just change.

A Sociology of Expectations in the ARF/RHD Network
The anticipation of success and efficacy of a Group A Strep vaccine accentuates the need to
engage with the future of technologies as a charged temporal space that plays an organising
role in current network processes (Brown and Michael 2003). I integrate a sociology of
expectations analysis into this chapter, drawing on ideas from Brown and Michael (2003), to
examine the ways the actor-network is shaped around hopes for innovative technologies
that offer imagined solutions to current concerns. This approach orients this analysis
towards the examination of technological innovations in terms of how actors’ views of
success and failure of a technology shift over time. These views move along a narrativized
continuum of “optimism-disappointment” as actors retrospectively consider past failings,
and prospectively ponder hopes for success (p. 14). The power of prospective hope enables
actors to assemble in unique ways around an innovation that would possibly have never
emerged, had it not been for this optimistic imagined future. In cases of disappointment,
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retrospectively derived expectations of future failure can preclude the construction of
technoscientific arrangements from ever eventuating. Through this lens, I consider ways
that a network is materially constructed by discursive production processes that translate
knowledge over time, making and unmaking connections through consensuses and
resistances (Baiocchi, Graizbord and Rodriguez-Muniz 2013, p. 337) in ARF/RHD prevention.

Group A Strep Vaccine: The Hundred-Year Promise of Disease Eradication
Development of a Group A Strep vaccine has a long history with many challenges and
obstacles to the emergence of a viable product for human use (Steer et al. 2009, p. 544).
Since the 1920s researchers have investigated various features of Group A Strep as potential
vaccine targets (RHDAustralia 2020, p. 286). One issue contributing to the slow progress in
vaccine development is the role of Group A Strep itself. Group A Strep is a devious,
adaptable, and complex microbial being. It is the cause of many human diseases that vary
greatly in terms of impact, site of infection, duration, and long-term effects (Mills and Ghosh
2021). It attacks many sites of the human body, commonly entering via the nasopharyngeal
passage or the skin, and can become deadly through invasive colonisation, such as in
infective endocarditis (RHDAustralia 2020, p. 286). This bacterium does not act alone,
sometimes joining forces with other pathogens, such as ectoparasitic scabies that open
wounds in the skin, easing bacterial passage and transmissibility in overcrowded and
unhygienic settings (Swe, Reynolds and Fischer 2014, p. 585; Thornley et al. 2018). Group A
Strep is well adapted to its pathogenic role and has evolved to respond to immune defences
adeptly (Mills and Ghosh 2021), using the human body against itself by causing
autoimmunity and mutating rapidly to avoid immune recognition (Reglinski and Sriskandan
2015).

Scientists have segregated two main categories of Group A Strep characteristics that
perform as the targets for vaccine research. These are “M-protein” and “non-M-protein”
research (Steer et al. 2009). M-proteins cover the surface of Group A Strep and collect
immune agents as a shield against clotting factors and other immune cells that would
otherwise seek to clear the bacteria from the human body (Mills and Ghosh 2021). There
are many types of M-proteins, and they are associated with the autoimmune reaction
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leading to ARF/RHD complications (Gray et al. 2017). These virulent characteristics make the
M-protein a difficult target for vaccine research due to associated safety risks of unintended
cross-reactivity with host tissues (Kumar and Tandon 2013). Alternately, non-M-protein
targets include other bacterial components that are significantly less studied (Steer et al.
2009). Non-M protein characteristics are generally more conserved across Group A Strep
types and do not appear to impact cross-reactivity. By challenging almost every aspect of
standard vaccine development through its multi-strain, mutational, virulent, and covert
qualities, the material and functional characteristics of this bacterial actor has strongly
contributed to repeated failed vaccine innovations for one hundred years.

Failed Pasts and Optimistic Futures for a Vaccine
In the ARF/RHD network, processes of knowledge and power emerge through discourse,
shaping expectations and imaginations of what the future network arrangement could look
like with a vaccine. The significance of examining future expectations lies in the rising
optimism for a vaccine over time and its various commercial and practical failures that
permeate, yet do not weaken, the strength of that narrative from advocates. The future
network is hence a charged space, not a vague undefined region, but rather a tangible
subject of analysis (Brown and Michael 2003). To examine the phenomenon of evolving
perspectives that mobilise network actors, I explore discursive changes seen across the
three editions of the Australian guidelines for ARF/RHD including the 2006, 2012, and 2020
publications. The ways these guidelines address interrelated issues of vaccine development
and disease prevention indicates changing hopes, driven by the accumulation of knowledge
and tools over a fourteen-year period. These expectations reflect the pressures, resistances,
and accelerations derived through the authors’ fluctuating interactions with other elements
within the dynamic sociotechnical web of ARF/RHD relations.

The First Edition: Mobilising Action
In the summarised version of the 2006 guideline, Diagnosis and management of acute
rheumatic fever and rheumatic heart disease in Australia, the authors present the first
national, evidence-based approach to addressing endemic ARF/RHD (Carapetis et al. 2007).
The focus of this publication is on detection and treatment of ARF/RHD and does not
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address primordial prevention strategies. The reason for not including these “is because the
key to primordial prevention is reducing exposure to GAS, which requires dramatic
improvements in housing, hygiene infrastructure and access to health care for Indigenous
Australians” (Carapetis et al. 2007, p. 582). At the time, these objectives were presented as
unattainable without systemic change and extensive resourcing and so were not a central
priority, unlike in later editions. This omission demonstrates the ways that material factors,
such as funding and resourcing, can play into perceptions of possible realities and futures. In
this edition, the focus lies on discrete and entrenched biomedical interventions that had
already been practically applied for some years, such as BPG injections as a secondary
prevention technique.

Further, the language used regarding Indigenous communities was restricted to the need
“to provide education and health promotion for individuals, families and the community”
(Carapetis et al. 2007, p. 585). This framing positions Western knowledge-holders as the
deliverers of essential information, indicative of a one-sided knowledge translation from
researchers to communities within the network. This unidirectional communicative
technique situates Aboriginal and Torres Strait Islander peoples within the deficit model of
healthcare knowledge (Heard et al. 2019, p. 872), emphasised by the absence of Indigenous
voices and viewpoints in this early agenda.

The absence of discourses of expectations from authors regarding the involvement of
vaccines as a technological actor in this edition can be attributed to several temporally
significant network processes. An extended moratorium was imposed by the Food and Drug
Administration (FDA), halting human vaccine trials involving Group A Strep in the United
States from 1979 to 2006 (Food and Drug Administration 2005). This ban was imposed due
to an experiment that seemingly caused ARF in several participants (Steer et al. 2009, p.
548). Group A Strep is a pathogen specialised to attack only human hosts and the restriction
of investigations to inappropriate non-human animal models contributed to successive
failures to deliver a viable vaccine (Osowicki et al. 2019, p. 3486; Rivera-Hernandez et al.
2019). While scientific research continued throughout the FDA ban era, there was a lack of
regulatory support, commercial interest, and prioritisation of Group A Strep as a global
health concern. This meant that the prospects of a successful vaccine emerging were
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uncertain until a consensus could be reached and regulatory barriers removed (Bisno et al.
2005). Rather than focusing on an imagined future actor, the Rheumatic Fever Guidelines
Writing Group of the National Heart Foundation of Australia (NHFA) aligned their focus
upon seemingly attainable goals for 2006. A vaccine was not presented as a major player in
the ARF/RHD network of Australia at this time. Instead, the focus was on projects that could
be started or improved immediately, including the implementation of coordinated control
programs, registers, and standardised diagnostic and treatment regimens.

The Second Edition: A Preventative Shift
In The Australian guideline for prevention, diagnosis and management of acute rheumatic
fever and rheumatic heart disease (2nd edition) published in 2012, there were significant
changes from the previous release, indicating shifting expectations over time, particularly
surrounding vaccine development and primary prevention.

In 2009, following extensive advocacy from a specialty group of researchers and clinicians,
the Commonwealth Government established RHDAustralia (RHDAustralia 2019b), which
emerged as an effect of many relations between human and non-human actors. This
ensemble of stakeholders included researchers, research, money, health professionals,
health resources, and Aboriginal and Torres Strait Islander peoples, interested in the
reduction of the preventable burden of ARF/RHD in remote communities. The
establishment of this heterogenous body shifted the Australian ARF/RHD network from a
somewhat disjointed, fragmentary conformation into a more solidified arrangement,
stabilising across shared intentions to prevent disease in remote communities. Coupled with
the Rheumatic Fever Strategy (Health Policy Analysis 2017), this amalgamation of interested
parties accelerated national efforts to establish register-based control programs in order to
share data across jurisdictions. Additionally, the assemblage of the National Coordination
Unit (NCU) signalled a joint commitment for the eradication of ARF/RHD through
dissemination of evidence-based guidelines direct to communities, in close partnership with
National Aboriginal Community Controlled Health Organisations (NACCHO). Professor
Jonathon Carapetis, the then Director of RHDAustralia, celebrated the novelty of this
coordinated venture saying there is “no other equivalent of RHDAustralia in any other
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country” and suggested that these united efforts are looked upon as an example to aspire to
in other ARF/RHD burdened regions of the world (RHDAustralia 2019a).

The RHDAustralia writing group prepared the 2012 edition of the Australian guidelines with
a focus on prevention that had not been addressed in the 2006 NHFA version. The language
used in this edition indicates the changing shapes of future expectations surrounding
ARF/RHD eradication via development of a vaccine actor as a preventative agent, as well as
new opportunities for enhancing community understanding of ARF/RHD risk factors.
Vaccines are first mentioned in this text as the “ideal solution for the primary prevention of
ARF/RHD” through their potential to protect against Group A Strep colonisation
(RHDAustralia 2012, p. 22). Following this statement, the idea of a vaccine is constructed as
utopian due to the long history of “scientific and regulatory obstacles” and safety risks
resulting in the failure to deliver on the promise of this preventative actor over many years.
The authors then describe a pertinent concern with vaccines in development: that targeting
the Group A Strep strains present in North America will not address ARF/RHD in endemic
regions elsewhere that have extensive strain diversity. This section is then closed with the
following quote; “While the development of a safe and effective GAS [Group A Strep]
vaccine to prevent ARF/RHD is yet to be realised, it should remain a priority in ARF/RHD
prevention” (RHDAustralia 2012, p. 23). The “optimism-disappointment narrative” of a
sociology of expectations (Brown and Michael 2003, p. 14) emerges in this statement as
authors of the guideline indicate the co-existence of disappointment in past failures and
concurrent optimism for the future of a vaccine that will prevent Group A Strep colonisation
from the outset.

Throughout this text Indigenous communities are discussed by the authors as groups
requiring “awareness” (p. 12, 30, 60), “education” (p. 16, 53, 67, 68, 69), and “involvement”
(p. 25, 71) in recommended programs. The added focus on prevention is a meaningful
transition from the previous edition as it acknowledges the growing importance of health
promotion, communication, and resourcing required to equip Aboriginal and Torres Strait
Islander communities with access to the biomedical knowledge of Group A Strep
management. However, similar to the first edition, writing about Indigenous peoples and
their participation in terms of a unilateral knowledge transfer again infers a knowledge51

holder vs knowledge-receiver relationship, rather than “the reciprocal process of co-creating
knowledge” in genuine, empowering partnerships (Haynes et al. 2019, p. 42). The 2012
edition thus demonstrates network stabilisation around both the idea of a new vaccine and
the promise that educating Indigenous peoples about biomedical techniques of prevention
could lead to a reduction in the burden of ARF/RHD.

The Third Edition: ‘Game-Changing’ Technology and Transformative
Collaboration
RHDAustralia recently released The 2020 Australian guideline for prevention, diagnosis and
management of acute rheumatic fever and rheumatic heart disease (3rd edition). In the
eight-year period between this version and the second edition, major changes occurred in
the ARF/RHD network, both in Australia and globally, with the convergent release of a
roadmap for the achievement of a vaccine (Vekemans et al. 2019).

In the years since, there has been an electrifying effect across the Australian ARF/RHD
network with actors gathering to enable the production of conditions that would facilitate a
successful and safe vaccine. The third edition echoes this renewed enthusiasm and the
innovative potential within the existing ARF/RHD network arrangement. Consequential
aspects of this evolution are signified by the integration of a new stand-alone chapter for
“New Technologies” which introduces the Group A Strep vaccine as a key player in the
network future. In addition, a chapter dedicated to “Primordial prevention and social
determinants of acute rheumatic fever” was introduced, signalling a concurrent network
shift towards addressing root causes of endemic illness in remote Indigenous communities.

The “New Technologies” chapter indicates that the authors align strongly with the WHO
priority for developing “Key Capacities” for vaccine development. An example of this is the
need to develop a human model of Group A Strep infection for “proof of concept
evaluation” in future clinical vaccine trials (Vekemans et al. 2019, p. 878). In the guideline,
investigations for a novel model of Controlled Human Infection for Vaccination Against S
pyogenes (CHIVAS-M75) by Australian researchers Osowicki et al. (2019), is presented as an
indication of emerging key capacities. Osowicki et al (2021), successfully developed the first
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safe and efficacious model of experimental Group A Strep pharyngitis for study of the
disease in humans a year after the release of the 2020 edition. This was a major step
towards the achievement of at least one WHO priority and sewed hope back into the
ARF/RHD network fabric. This meaningful finding confronted, and scientifically controlled,
many unpredictable aspects of Group A Strep infection and recovery, moving the network
one step closer to eventuation of a vaccine.

The “New Technologies” chapter of the 2020 guidelines emphasises persistent hope and cooccurring reflection upon past failures in the vaccine narrative. Acknowledgement of failures
is not always disastrous and maintaining narratives of future success can sometimes
perform as a “self-fulfilling prophecy” (Pollock and Williams 2010, pp. 528-529). The authors
emphasise the wide-reaching positive impact that a Group A Strep vaccine would have for
some of the most “severe and frequently fatal invasive disease” affecting vulnerable people
in endemic areas, such as “pregnant women and newborn babies” (RHDAustralia 2020, p.
286). They then acknowledge past failures of other programs for primary prevention, saying
“antibiotic treatment for Strep throat and skin infections have not been able to achieve
large and sustainable reductions in the subsequent development of ARF or RHD” (p. 286).
They suggest that a vaccine would be a more sustainable form of long-term intervention and
a short-term primary prevention solution as well.

Overall, the authors remain overwhelming optimistic that a vaccine “will help eliminate
disease” (p. 286). This future-focused enthusiasm is bridled by reflection upon multiple past
failures driven by “scientific, regulatory and commercial obstacles” (p. 287). This
demonstrates that over time the socio-political and material contingencies linked to vaccine
success or failure have become increasingly apparent. As Borup et al. (2006, p. 286) argue,
we see here that “expectations are both the cause and consequence of material scientific
and technological activity”. The insertion of $35 million from the Federal Government
towards Group A Strep vaccine research bolstered a growing hopefulness across the
research dimension of the network. This “catalytic” investment (Telethon Kids Institute
2021) has demonstrated that accelerated hopes are linked inextricably with material
associations. Brown and Michael (2003) suggest in relation to other novel technologies, that
multi-sectoral, institutional engagement can feed into the actual success of a technology in
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the future. As this guideline seems to suggest, without the necessary resourcing through
funding and institutional support, the vaccine remains a far-off dream yet through
substantial monetary, regulatory, and governmental backing, the network alignment around
a vaccine is better protected against future unknowns.

The influence of material network elements on innovative change becomes more apparent
through consideration of the discourses that accompanied the third edition. At a conference
in 2019 the Chief Executive Officer of NACCHO, Pat Turner, a key collaborator in
RHDAustralia initiatives, emphasised simultaneous support for vaccine research and the
need to address material concerns of poverty and illness saying, “A Strep A vaccine would
be a game-changer, but developing it will take years and people are dying now – we need to
make sure that the really exciting investments in science are coupled with on-the-ground
action,’ (NACCHO Aboriginal Health News Alert 2019). This need for primordial action before
the pursuit of a technological solve-all is demonstrated through the near-eradication of
ARF/RHD in mainstream, non-Indigenous Australia, where standards of living are generally
high and easy access to services is the norm (Steer 2015, p. 22). The inclusion of a new
chapter attending to the social determinants of health signals that the emerging discourse
in 2020 has evolved through the integration of multiple knowledges and the elevation of
Indigenous voices. An example of this is in the Foreword prepared by the newly appointed
Director of RHDAustralia, Vicki Wade. In this section, Wade, a Noongar woman of SouthWest Western Australia, highlights that ARF/RHD “challenges are more than biomedical and
are driven by the social, cultural and environmental determinants of health” (RHDAustralia
2020, p. 2). This rising emphasis of the systemic causes of illness hints at the emergent social
justice narrative that attends explicitly to the role of “cultural and structural barriers for
Aboriginal and Torres Strait Islander peoples” (p. 14) and the ongoing impacts of
colonisation that have become increasingly important considerations in ARF/RHD health
programs (Haynes et al. 2021, p. 8). Additionally, language used in relation to Indigenous
communities has shifted immensely since 2012 to become more collaborative and less
paternalistic. For instance, instead of a predominant preventative approach of educating
and prescribing Western knowledge, this edition focuses more on Indigenous community
“capacity and governance” (p. 9), “relationships” and “partnerships” (p. 10), “holistic” views
of health wellbeing and care (p. 9, 10, 36, 249, 252), “priorities and preferences” (p. 40),
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“trust” (p. 50, 112, 160, 200), and “ownership” (p. 60, 275). This language signals a move
towards a transformative narrative of empowerment through reciprocity, emphasising the
need to engage in community-led approaches beyond biomedical understandings of disease
management into the future.

Conclusion
In this chapter I considered the ordering influence of material elements and the future as a
charged temporal space within the ARF/RHD network. By examining Group A Strep as an
actor with intentions to evade immune defences and evolve beyond the grips of vaccine
protection, I highlighted some of the fundamental historical issues that have slowed the
innovative processes for vaccine development. However, as techniques for scientific
exploration expand, the investigation of new, conserved targets that are found across
multiple strains could be the key to newfound scientific discoveries. This scientific enquiry is
contingent on the many associated actors and material realities of the ARF/RHD network
that either support or hinder the pursuit of a vaccine. To demonstrate this ongoing dynamic
struggle, I explored the discursive development of three editions of the Australian guidelines
for ARF/RHD and how they evolved over time. The prospective hopes for a vaccine have
changed in profound ways since 2006 that highlight the effects of network processes,
shifting related actors into a state of convergence and stabilising them around support of a
vaccine by 2020. Perhaps most crucially, the emergent role of Indigenous leadership in the
recent edition encapsulates a radical turn in narrative structure from a heavy focus on
surveillance in 2006, to a growing emphasis on prevention in 2012, and finally towards a
concerted effort to convince the readership that primordial prevention presents the best
prospects for holistic, sustainable health improvements for remote Indigenous communities
of Australia in 2020. By retrospectively considering prospective discourse surrounding
vaccines and how this has developed over time, it becomes clear that optimistic ideals for
change have the potential to shift network flows and conformations in the future, stabilising
around actors that promise a world with less ARF/RHD.
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Chapter 6: Conclusion
In this thesis I have undertaken a sociological analysis of some of the socio-technical and
material aspects of the acute rheumatic fever and rheumatic heart disease (ARF/RHD)
network in Australia that have led to the endemic and ongoing presence of disease in
remote Aboriginal and Torres Strait Islander communities. Further, I have considered how
the construction of the ARF/RHD network has changed over time through movement of
actors and dynamising processes that pervade the network space, shifting actor positions
around emerging and retrospective opinions, perspectives, and expectations. These
assembling processes and arrangements were examined through an actor network theory
(ANT) perspective, supplemented with ideas from ethics of care, governmentality theory,
and post-colonial studies. Through this combination of analytical lenses, I have contributed
new insights to the sociological literature on this topic through investigations of key
technological nodes in the ARF/RHD network, illustrating the ways that the seemingly
disparate human and non-human elements of technoscientific assemblages are contingent
and dependent on related actors and do not arise in isolation. This contingency illustrates
the ways that network formation is a dynamic, cumulative process of flowing network
energies that are shifted, interrupted, reversed, or enabled over time through discursive and
material inputs from diverse actors.

As the scope of this inquiry was confined to an Honours thesis, I have focused on three
network nodes, however, there are countless possible focuses, both human and nonhuman, that could be considered. Future research into this topic could involve; (1) analysis
of primordial prevention nodes such as housing, water, and nutrition; (2) consideration of
the racialised and gendered aspects of ARF/RHD through contraceptive, pre-natal and postnatal interventions; and/or (3) exploration of Aboriginal and Torres Strait Islander peoples’
systems of governance, knowledges, and management of ARF/RHD and other illnesses
across diverse communities.

By investigating network associations linked with three technologies, I have exposed some
of the ways that the ARF/RHD network has been historically developed through a
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biomedical lens of healthcare that is heavily reliant on discrete technological interventions
for the management of ARF/RHD in remote Indigenous communities. In considering
benzylpenicillin G (BPG) injections I was sensitised to the issues that can emerge through
culturally incongruent translations of knowledge during healthcare interactions and the
reliance on unsustainable systems of prevention dictated by distant corporate ensembles.
However, I identified that this can be changed through the sharing of responsibility for care
across other actors and with engagement characterised by reciprocal communication.
Through contemplation of the diverse sources of care available in the ARF/RHD network, I
suggest that attempts to realign the position of BPG injections as just one of many
preventative actors, rather than as a mainstay of prevention could facilitate a transitionary
move towards primordial prevention strategies that address root causes of disease. By
looking at echocardiograms (ECGs) I found that the standardisation tools, such as criteria,
that emerge to visiblise historically obscured network elements of ARF/RHD in remote
communities, are often contested despite their apparent enrolment as the gold standard of
diagnosis. Additionally, standardisation can lead to the establishment of jurisdictional
network barriers through professionalisation processes that become a site of resistance as
actors work to facilitate non-expert empowerment via localised education of health staff.
Finally, the exploration of Group A Streptococcus (Group A Strep) vaccine development then
drew my inquiry into the future of the ARF/RHD network as a charged temporal space of
investigation, whereby the narratives of success in the future and disappointment in past
failures collided with the contingent material elements required for the construction of a
hopeful discourse. This led me to understand that the current expectations for a future free
of ARF/RHD is contingent on complex socio-material interactions of the past. This opening
up of the network to an optimistic future of collaborative change is ever-evolving as new
actors and knowledges are introduced and shift existing network flows and arrangements
over time.

Overall, my investigation has demonstrated that the ARF/RHD network is a dynamic
sociotechnical space that has been subject to immense energetic fluctuations that pervade
the network and shift actors based on contested and emerging understandings of best
practice for prevention and treatment of this endemic disease. While many policy makers
and health practitioners consider ARF/RHD as an intractable, stationary reality, I believe this
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inquiry has exposed the vast potential for change to occur into the future of the ARF/RHD
network, through both material and epistemological rearrangements. The stabilisation of
the network conformation around various historical and emergent interventions is a key
feature of this health issue. These semi-solid conformations can be fluidified through
convergent communicational and material inputs from diverse actors that see the potential
for a holistic shift. By confronting the assumptions underlying the biomedical knowledge
processes systemically diffusing the current entrenched network assemblage, resistant
actors can redirect energies to reverse the flow of power and knowledge, reassembling the
network into a more socially just conformation, built around community-led projects for
collaborative primordial prevention of ARF/RHD. This does not preclude new and
established technologies and biomedical insights. Rather, it asserts the value and elevates
the importance of Indigenous knowledges, cultures, and leadership in the future
configurations of the ARF/RHD network of Australia.
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